BeiGene is one of several drugmakers and biotech firms seeking to raise funds in Hong Kong after the city revamped its listing ruleshttps://on.wsj.com/2OEQyAA
3 replies
10 retweets
22 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.